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The Ehlers-Danlos syndrome has been classified into 
nine phenotypic presentations. Type IV is a variant of 
particular importance because people affected with 
this genodennatosis are at great risk of spontaneous 
hemorrhage from vascular rupture or bowel perfora-
tion. Recent molecular advances have identified mu-
tations in the gene for type III procollagen as respon-
sible for Ehlers-Danlos syndrome type IV. We report 
a case of a 14-year-old male with a typical presenta-
tion of the type IV variant who was found to have 
markedly dilated fibroblast cisternae and varying 
T he Ehlers-Danlos syndrome (EDS) is characterized by hypermobility of the joints, hyperextensibility of the skin, easy bruising, and increased skin fragility [1-4]. The nine subtypes of the syndrome have been characterized according to phenotypic features and 
underlying biochemical defects. EDS IV is caused by defects in type 
III procollagen, EDS VI by mutations in the gene for lysyl 
hydroxylase, EDS VIlA and B by defects in the gene for type I 
procollagen, and EDS VIIC by deficiency of procollagen N-
proteina.se [l-4]. 
EDS IV is of particular importance to clinicians because sponta-
n eous rupture of large blood vessels, bowel, or pregnant uterus may 
occur, leading to sudden death [1-4]. We describe a. case ofEDS IV 
with a classic phenotype caused by a novel biochemical defect. Our 
findings further illustrate the heterogeneity of biochemical defects 
found in EDS. 
MATERIALS AND METHODS 
Case Report A 14-year-old boy presented to our dermatology clinic for 
evaluation after being treated for a spontaneous 1-cm perforation of the 
sigmoid colon that res ul ted in a colostomy. The patient was born at 34 
weeks of gestation and weighed 3 lb 2 oz at birth. He was the product of a 
consanguineous relationship between his mother and his maternal grand-
mother' s brother. His history was remarkable for easy bruisability and 
bleeding tendency, · hypcrextensible fingers, and bilateral inguinal hernia 
repair at 3 months of age. 
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collagen fibril diameter on ultrastructural study. A 
novel genetic defect was noted by polymerase chain 
reaction and DNA sequencing of genetic material 
isolated from skin fibroblast cultures. Analysis of the 
gene for type III procollagen revealed a single base 
mutation in the last nucleotide of exon 34. The 
mutation led to abnonnal RNA splicing and skipping 
of exon 34 on the mRNA level. Key JVords: DNA 
seqlle11ciug/PCR/nmtatiou a11alysisldilated ro11gh e11doplas-
mic retic11l11m. J I11vest Dermatol 105:352-356, 1995 
The patient's family history was remarkable for his mother's death at age 
16 secondary to colonic rupture and the death of two maternal aunts: one 
at age 3 after a fever and the other at age 5 after an appendectomy. His 
maternal grandfather rued at age 22 secondary to peritonitis. The consan-
guinity suggested the possibility of recessive inheritance of the disease. 
However, both the clirucal data, which indicated no evidence of the disease 
in the maternal grandmother's side, and the sequencing results (see Results) 
supported dominant inheritance of the mutation and disease. 
Physic~] examination revealed hyperextensible fingers and elbows, hy-
perextensible skin, and "f1slm1outh" scars over the elbows and knees. 
Light and Electron Microscopy Biopsy specimens from the left upper 
inner arm from the patient and from a control individual were taken and 
prepared for light and e lectron rllicroscopy. The specimens were initially 
fixed in a solution containing 3.75% glutaraldehyde, 6% sucrose, and 0.1 M 
sodium cacodylate (pH 7.4), washed in cacodylate-buffered sucrose, and 
post-fixed in cacodylate-buffered 1% osmium tetroxide. One-micrometer 
sections were cut from samples embedded in epmry resin, stained in a 
mixture of toluidine blue and basic fuchsin, and examined by light 
microscopy. Additional ultrastructural analysis was performed using a 
Philips 400T electron mictoscope. 
Polymerase Chain Reaction (PCR) and Sequencing To prepare a 
eDNA template for PCR [5], we isolated total RNA from cultured skin 
fibroblasts using a procedure involving extraction with guanidium isothio-
cyanate [6]. The RNA was purified by centrifugation through a cesium 
chloride gradient and used to synthesize the first strand of eDNA \vith 
MMLV reverse transcriptase (Bethesda Research Laboratories). To isolate 
genomic DNA templates for PCR, we extracted DNA from cultured skin 
fibroblasts using an automated procedure (Genepure 340; Applied Biosys-
tems). 
ln initial experiments using eDNA as a template for PCR, sets of oligo-
nucleotides were used as primers to generate overlapping products that 
included aU the coiling sequences of the triple helical domain [7-9]. Primers 
and PCR conditions were as published previously [8]. Because one of the 
PCRs resulted in two bands, as compared with one in the controls, three 
additional sets of primers were used (namely, primers lll-5 and SP31, SP1 0 
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and SP4, SPl 0 and SP30) to localize more closely the area where some 
sequences were missing from the eDNA. T he PCR. products were purified 
u sing a glassmilk method (Gened ean II, Bio101) and sequenced directly 
Wi tbout cloning using internal primers specific for the rype III procollagen 
eD NA (6-8). 
For experiments in which tl1e goal was to detennine the level of 
e"--pression from the two COL3Al alleles , the eDNA was used as a template 
in PCR with primers 111-4 and Ill-S (8] to cover an area that contains a 
single base polymorphism [10]. Primer rii-4 was radioactively end-labeled, 
and 15, 20, and 25 cycles of PCR were carried out. The products were 
digested with A /ul and then separated on polyacrylamide gel. Quantitation 
was performed with phosphor storage screens (Phosphorlmager; Molecular 
Dynamics). 
To use the genomic DNA as template for PC R, we used two oligonu-
cleotide primers: FIM-1, CTGTAAGATCTTACATGACATCCT, located 
in intron 33; and FIM-2, TCTCAGGCAAAGATTCTATAGGC, located in 
intron 35 [11]. The PCR product was purified using a glassmilk method and 
sequenced directly without cloning using primer H-9 , GAGGCTTGTGTT-
TACTGAGC (located in intron 33 [11]). The PCR products from the 
patient and two controls were also analyzed with restriction endonuclease 
B stEll digestion followed by agarose gel electrophores is. 
Analysis for Potential 5' Splice Sites To score normal , mutant, and 
potential 5' splice sites witi1 ti1e modified (12) meiliod of Shapiro and Sena-
pathy (13], we searched the sequences for -gt- dinuclcotides and 
c omputed a score for the three nucleotides preceding and the four 
nucleotides followin g the - gt-. 
Definition of RNA Splicing Patterns To study furti1er the different 
species of mRNA, we perfom1ed radioactive PCR s. The primer combina-
tion in the PCRs was SP10 with SP31 or SPl 0 with SP4 . SP10 primer was 
radioactively labeled with T4 polynucleotide kinase and -y-32P-ATP (NEN / 
DuPont) . PCR.s were carried out for 10, 12, 14, 15, 17, 19, 21, 23, or 25 
cycles. After PCR, the samples were mixed with a solution of fomlaldc-
h yd e, bromophenol blue, and xylene cyanol; hea ted at 95 °C for 3 min; 
cooled on ice; and loaded on 6% DNA sequencing gel (Sequagel-6; 
National Diagnostics). After electrophoresis, the gel was fixed, dried, and 
exposed to x-ray film and Phosphorlmager screen. T he results were 
quantitated by Phosphorlmager (Molecular Dynamics). 
RESULTS 
A skin biopsy specimen from the left an11 of the patient revealed no 
abnormalities on light microscopy. Electron microscopy revealed 
markedly dilated rough endoplasmic re ticulum of fibroblasts, with 
cisternal contents filling a disproportionate amount of the cytoplas-
mic volume (up to 75% of the cytoplasmic volurne in selected cells) 
(not shown). T he collagen fibe rs appeared in disarray, as they w ere 
irregularly packed . They also displayed a wide range of widths, 
from 74 to 174 nm. 
Because most [1-4,11 ,12,14-31], if not all, patients with EDS IV 
have mutations in the gene for type III procollagen, the coding 
sequences for type III procollagen were analyzed using PCR and 
direct sequencing. Total RNA was isolated from cultured skin 
fibroblasts, single-stranded eDNA was prepared from the RNA, 
and PCR was p erformed using the eDNA as a template and sets of 
overlapping primers for the type Ill procollagen [8 ,9]. The PCR 
covering nucleotides 1909 to 2955 [7) gave two produc ts with the 
proband's eDNA, whereas the eDNA prepared from the control 
cell line gave only one band on agarose gel. T h e abnormal band 
migrated faster and was approxin1ately 50 bp shorter than nom1al. 
T hree additional PCRs (Fig 1) with different sets of prin1e rs 
followed by restriction enzyme digestions with six d.iiferent en-
zymes confirmed (not shown) the result and incticated that the 
abnormally migrating band most likely represented a species of 
mRNA la cking the sequences derived from exon 34 of the gene for 
type III procollagen. Direct sequencing of the PCR product 
c overing nucleotides 1909 to 2955 revealed a mixed sequence 
starting at the border of exon 34. The sequen ce was a mixture of 
nonnal sequence , de rived from the nonnal allele for type III 
procollagen, and a sequence missing exon 34, derived from the 
mutant allele. All the other sequences detennined were normal 
from nt 457 to nt 2385 and from nt 2440 to nt 3700 (numbered 
according to [7]). The proband was found to be h e terozygous for 
the nt 2092 polymorphism located in exon 31 of the COL3A1 gene 
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Figure 1. About half of the eDNA from the proband is miSsmg 
exon 34. A , agarose gel and etiudium bromide staining for PC R products 
using control (C) and proband's (P) eDN A as template. M, molecular size 
marker, 123-bp ladder. B, schematic presentation of type Til collagen eDNA 
from the area of interest covering exons 28 to 40. Horiz omal mrows, location 
of primers for ti1ree separa te (!, 11, Ill) PCR.s; Jleltical mTOII' , ex on 34. 
[10] . T h e re fore, at the mRNA level, the patient expressed both 
alleles and was heterozygous for only one mutation, which caused 
the deletion of the coding sequ en ces of exon 34 from the mRNA 
of one allele. 
To determine the mutation on the genomic DNA level, we u sed 
the proband 's genomic DNA as the template for PCR using prin1ers 
d erived from sequences in i.ntron 33 and 35 [10] . Sequencing of the 
PCR product revealed a single base ch ange: the last nt of exon 34 
was A in the mutant allele and G in the normal allele (Fig 2). T h e 
nom1al 5' splice site AAG gtaacc h as a site for restriction endonu-
clease BstEII, th e recognition sequ en ce of which is .G/GTNACC 
l\_ 
G 
GIA--. 
A 
lf 
Figure 2. The last nucleotide of exon 34 of the gene for type ill 
procollagen from the proband is mutated. The sequence is in sense 
orientation. A n·ow, G to A mutation of ti1e last .nucleotide of exon 34 . 
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Figure 3. B stEII digestion of PCR products from genomic DNA 
templates of three separate DNA isolations from the proband 
(EDS) and the two unrelated controls (Cl and C2) confirms the 
mutation. A, agarose gel and ethidium bromide staining for PCR products 
after BstEII digestion. </JX Hnelll, molecular size marker. B, schematic map 
of the re.gion of the COL3Al gene around exon 34. FIM-1 and FIM-2, 
primers used in PCR; mrow, site of mutation and normally occurring site for 
BstEil. 
(the underlined base was mutated h e re). The mutation abolished 
the site for BstEII. The presen ce o f the mutation was confirmed by 
digesting the PCR product with BstEII (Fig 3). 
The sequen ces of intron 34 were searched for potential 5' splice 
sites u sing the method described pre viously [12 ,13] . Intron 34 is 
only 86 nucleotides long, and it contains a total of three -gt-
dinucleotides. The first -gt- dinucleotide is p art of the normal 5' 
~plice site. The numeric score obtained for the normal site w as 69 
(Table 1). The mutated 5 ' splice site had a score of 51 , and the 
other two -gt- dinucleotides were surrounded by sequences that 
yielded scores of 28 and 34, respectively (Table 1). 
We evaluated the effects of the mutation on RNA splicing u sing 
PCRs in w hich one of the primers was radioactively labeled and the 
products were run on polyacrylamide gel to enhance resolution and 
de tection of fragments . The results shown in Fig 4A indicated that 
the proband' s sample contained two species of mRNA, one of 
normal size and the other 54 nt shorter , lacking the sequences 
corresponding to exon 34. Even extended exposure using phosphor 
storage screen did not reveal any additiona l bands in the gel. 
Quantitatio n of the inten sity of the bands indicated that the band 
Table I. Evaluation of Normal, Mutant, and All 
Potential 5' Splice Sites With -gt- in lntron 34 of the 
Gene for COL3A1 Demonstrates That No Cryptic Sites 
with Good Scores Are Available" 
5' Spl.i ce Site 
Nonn al 5' site (+1)-AAG gtaacc 
Mutant 5 ' site (+ 1)-AAA gtaacc 
+37- aa t gtctct 
+ 62-aca gtgaca 
Numeric Score (%) 
69 
51 
28 
34 
" Performed according to the method of Shapiro and Scnapathy [13), with minor 
modifications [1 2). 
T H E JO URNAL OF INVESTIGATIVE DERMATOLOGY 
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Figure 4. Exon skipping is the only abnormal RNA splicing pattern 
caused by the mutation. A, polyacrylamide gel of radioactively labeled, 
two separate PCR products using control (C) and proband's (EDS) eDNA 
as template. T he 226-nt and 1 72-nt products were generated by using 
primers SPlO and SP31 [8], in the PCR, and the 327-nt and 273-nt products 
were generated by using primers SP10 and SP4 [8]. The PCRs were carried 
out for 15 cycles. B, schematic drawing of the exon skipping. E33, E34, and 
E35 indicate exons 33-35 of the COL3A1 gene. Sizes in bp indicate the 
lengths of exons and introns. Nucleo tide sequences show the last 3 nt of 
exon 34 and fir st 6 nt of intron 34 of tbc normal and mutant alleles of the 
proband . 
representing the RNA sp ecies in which exon 34 was rmssmg 
constituted about 50% of the combined radioactivity of the two 
bands seen on the gel. Using a polymorphism located at nt 2092 
(numbering according to ref. [7]) in exon 31 of the COL3A1 gene 
[1 0] as a marker, it was possible to show that both alleles w ere 
e"l'ressed at about the same level (not shown), indicating that exon 
skipping w as a very efficient way of RNA splicing from the mutant 
allele. 
DISCUSSION 
EDS IV is dominantly inherited and is the most severe form ofEDS 
[1- 4], although in most reported cases the fLrst signs and symptoms 
do not appear remarkable. The life- threa tening situation of arte rial, 
bowel, or uterine rupture usually develops su ddenly, without 
wanting signs [1-4]. The first indica tions that the patient has EDS 
IV are fragile, thin skin , easy bruisability, and hypem1obile joints, 
especially in the hands. Therefore, many patients with EDS IV are 
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first seen by a dermatologist, and it is very important that the 
syndrome be properly diagnosed. To improve the accuracy of the 
diagnosis in our patient, we performed electron microscopy on skin 
biopsy specimens. Although the analysis revealed variations in the 
diameter of the collagen fibrils and dilated rough endoplasmic 
reticulum in fibroblasts, these findings are not sufficiently specific 
for EDS IV to make an unambiguous diagnosis. Other investigators 
have similarly had difficulties in showing any specific changes of 
EDS in morphometric ana lyses [3 2-34] . 
Several different mutations have been detected in the gene for 
type HI procollagen in patients with EDS IV [11,12,14-31] (Fig 5) . 
The mutations characterized in detail to date were single base 
mutations convertin g glycine to another bulkier amino acid [11, 14-
22], RNA splicing mutations [12,23-28], and deletions [29-31]. All 
the patients in whom the mutations were characterized were 
heterozygous for the mutations, supporting dominant inheritance 
of EDS IV. Despite consanguinity in the current family suggesting 
recessive inheritance, the patient described here was heterozygous 
for the mutation and had inherited the disease dominantly. 
Use of the information from identified mutations for general 
DNA diagnostics has been difficult because, thus far, all of the 
(approximately 30) mutations reported have been unique to each 
family. Detection of mutations has been complicated by the large 
size and the compl exity of the gene, which has 52 exons in 
approximately 45 kb [1-4] . Once a mutation has been detected in 
a pedigree member, it is easy to develop a rapid screening test for 
the rest of the fam..ily [35] , but each family requires a unique test. 
The heterogeneity at the molecular level has been matched by the 
variability at the phenotypic level. Phenotypic variability is detected 
even within the same family [15]. It has therefore been difficult to 
detect any genotype-phenotype correlations. 
Here we report on a novel RNA splicing mutation in the last 
nucleotide of exon 34. T he mntation caused efficient removal of 
the sequences of exon 34 during RNA splicing. In the lite rature, 
this phenomenon has been referred to as exon skipping [12,36]. No 
other species of abnormally spliced RNA were detected, even 
when we used PCRs with radioactively labeled primers and 
sensitive detection methods. T he allele con taining the mutation 
was efficiently expressed on the RNA level, as no difference was 
detected in the amount of mRNA synthesized from the mutant and 
normal aUele when using a si11gle base polymorphism in exon 31 as 
a marker. Also, the exon skipping was very efficient, as approxi-
mately all of the mutant allele was shown to produce a shorter 
mR.NA. No evidence was found for the usc of potential cryptic sites 
in intron 34. The single base mutation in the last nucleotide of exon 
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Figure 5. Summary of all reported 
mutations in the COL3Al gene. 
Single base mutations are listed above 
the collagen triple helix using single-
letter a.mino acid code. Deletions and 
RNA splicing mutations are shown un-
der the triple helix . Horiz o11tol bors indi-
cate the area deleted . E34 (-1.) G~A 
refers to the new mutation reported 
here. Most mutations cause EDS TV, but 
the G619R mutation (35] was found in a 
family with arteria] aneurysms. 
34 reduced the numeric score of the 5 ' splice from 69 to 51. This 
was probably a significant enough reduction to account for the 
mis-splicing, as it meant that tl1e complementary of the 5' splice site 
to U1 snRNA [3 6] was reduced and it would, therefore, reduce the 
stabili ty of base paii;ng between the 5' splice site and Ul sn.RNA. 
To our knowledge, only two other cases have been reported in 
collagen genes i.n which the last nucleotide of an exon has 
influenced dramaticaUy the o utcome of RNA splicing [37,38]. 
These examples involve mutations in the genes for type I procol-
lagen in two patients with EDS VH, a subtype ofEDS with marked 
hypermobility of the joints [3 7 ,38] . These EDS VII patients also had 
G to A changes in the last nucleotide of exon 6, either in the 
COL1A1 [37] or in the COL1A2 [38] gene of type I procollagen. 
According to a recent review on RNA splicing mutations, four 
other examples from other genes exist in which the last nucleotide 
of an exon caused abnormal splicing [39]. 
Several factors in this case may have contributed to exon 
skipping rather than other fom1s of aberrant splicing. lntron 34 is a 
short i.ntron, being only 86 nt long. Although introns shorter than 
70 nt exist, most mammalian introns are longer, and it has been 
shown that introns less than 70 nt do not splice efficiently [36]. 
T herefore, intr·on 34 did not have much sequence available for 
cryptic splice sites, and those that were present had low numeric 
scores, suggesting that they were poor competitors . Although exon 
skipping is one of the most common fonns of aberrant splicing and 
is a predictable outcome of the exon-definition model for splicing 
[ 40], the inherent order of splicing of a pre-ml~A may also play a 
role [12,41]. Splice sites at the ends of most introns have evolved 
with the intron sequences to splice efriciently with respect to that 
intron and adjacent introns . It has been shown that diiferent pre-
ml'tNAs demonstrate a specific preferred order of intron splicing 
that is neitl1er 5' to 3' nor 3' to 5' [41] . The relative strengths and 
rates of interactions ofUsnJl..NPs <md other splicing factors with the 
splice sites most likely define the rate and, therefore, the order of 
intron removal. Naturally occurring mutations inmulti-exon genes 
contribute significantly to the understanding of splicing, as iu vitro 
studies are usually restricted to short model pre-mRNAs with few 
exons. 
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